Intravenously Administered M6229 in Critically Ill Sepsis Patients

Clinical trial NCT05208112 · COMPLETED

Trial details

NCT number: NCT05208112
Sponsor: A.P.J. Vlaar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sepsis Septic Shock Critical Illness

Start date: 2022-04-05
Primary completion: 2023-09-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.